Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001618071 | SCV001846322 | benign | not provided | 2018-06-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807451 | SCV002054520 | benign | Developmental and epileptic encephalopathy, 11 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807452 | SCV002054521 | benign | Episodic ataxia, type 9 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807450 | SCV002054522 | benign | Seizures, benign familial infantile, 3 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV004594411 | SCV005087297 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 91% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 85. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001618071 | SCV005239603 | benign | not provided | criteria provided, single submitter | not provided |